Semaglutide (low dose)
Ingredient · In our Low-Dose Semaglutide Injection
Semaglutide, at a lower dose
Semaglutide is a GLP-1 medication. It acts like a hormone your gut releases after you eat, one that helps your body manage blood sugar and insulin. Here it's prescribed at a lower dose with metabolic health in mind.1
Photo is an illustration, not the medicine. Semaglutide is made in a lab.
Semaglutide is FDA-approved to improve blood sugar control in adults with type 2 diabetes, and to lower heart and kidney risks in some of them.1 Prescribing a lower dose for metabolic health in people without diabetes is off-label, which means it's a clinician's judgment call rather than an FDA-approved use. Our semaglutide is compounded by a licensed pharmacy, and compounded versions are not FDA-approved.4
The studies below used FDA-approved products or other forms. Our compounded version hasn't been studied in trials, and results may differ.
What it is
Your gut makes a hormone called GLP-1 after you eat. It helps your body release insulin when blood sugar rises, quiets a hormone that raises blood sugar, and slows how fast your stomach empties. Semaglutide is a longer-lasting version of that signal, which is why it's given once a week.1
Why it's in this product
Blood sugar and insulin can get harder to manage in midlife. The FDA-approved version of semaglutide has been studied for blood sugar control.2 Low doses for this purpose haven't been tested in their own trials. Your clinician decides if it fits.
What the studies in people show
- Randomized trialLower blood sugar, even at the lower doseIn 388 adults with type 2 diabetes, weekly FDA-approved Ozempic (semaglutide) lowered HbA1c (a three-month blood sugar average) by 1.45 points at 0.5 mg and 1.55 points at 1 mg over 30 weeks, compared with almost no change on placebo.2
- Randomized trialHeart protection in type 2 diabetesIn adults with type 2 diabetes and high cardiovascular risk, FDA-approved Ozempic (semaglutide) lowered the combined rate of heart attack, stroke or cardiovascular death compared with placebo.3
What we don't know yet
These trials were in people with type 2 diabetes, and they used brand-name semaglutide at standard doses. Whether a lower dose helps metabolic health in people without diabetes hasn't been tested directly, and compounded versions haven't been studied head to head with the brand.4
Safety, in plain English
The most common side effects are nausea, vomiting, diarrhea, belly pain and constipation.1 Rarer but serious risks on the label include pancreatitis, gallbladder problems and low blood sugar when it's combined with insulin or certain diabetes pills. Semaglutide carries a boxed warning because it caused thyroid C-cell tumors in rodents, and it isn't used by people with a personal or family history of medullary thyroid cancer or MEN 2.1
A licensed clinician reviews your health history and decides whether semaglutide is appropriate for you. Exploring it here never means you'll get a prescription.
Curious about Low-Dose Semaglutide Injection?
Start with a free assessment. A licensed clinician reviews your health history and decides whether treatment is appropriate. No pressure, and no prescription unless it makes sense for you.
See Low-Dose Semaglutide InjectionHow care worksSources
- U.S. National Library of Medicine, DailyMed. Ozempic (semaglutide) injection: prescribing information. DailyMed
- Sorli C, Harashima SI, Tsoukas GM, et al. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1). Lancet Diabetes Endocrinol. 2017;5:251-260. PubMed 28110911
- Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834-1844. PubMed 27633186
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA
Sources checked November 8, 2026. This page is general education, not medical advice, and it doesn't mean any treatment is right for you. Photos: Unsplash (Adeel Shabir).